We are excited to announce an opportunity to contribute to the future of diabetes research in Australia.

Diabetes Australia and the Australian Centre for Accelerating Diabetes Innovation (ACADI) have collaborated to establish the Australian Diabetes Clinical Trial Network (ADCTN), a research initiative designed to increase clinical trial activity in Australia. Clinical trials ensure new treatments deliver real benefits to people, while also identifying any potential risks or side effects.

The ADCTN will support diabetes researchers by providing expert peer review and lived experience perspectives for clinical trial protocols, offering feedback to strengthen research protocols and proposals. Our purpose is to promote and facilitate local and international diabetes clinical trials in Australia.

Lived experience and expertise in diabetes clinical research are invaluable in ensuring new diabetes treatments deliver real benefits. We invite you to bring your voice and clinical insights to our new research network to help shape better outcomes for all affected by diabetes.

The ADCTN is currently seeking new members for the Executive Committee and the Reviewer Panel to help in the trial review process.

Open Positions

1. Executive Committee Member

• The Executive Committee governs and guides the activity of the ADCTN through scientific leadership, strategic management, and peer engagement.
• The Executive Committee will include both people living with diabetes and researchers experienced in conducting clinical trials.

2. Reviewer Panellist

• The Review Panel will be engaged on an as-needed basis for expertise in specific areas of diabetes. 
• Panellists will include both people living with diabetes and researchers experienced in conducting clinical trials.
• ADCTN will provide an annual certificate to acknowledge the contributions for those who review for the ADCTN. 

Click here to submit your expression of interest:

https://q.surveys.unimelb.edu.au/jfe/form/SV_9XFNnwj8g0e7pXw